Valink Therapeutics
Valink offers innovative solutions for cancer treatment using a proprietary platform called LiliumX™, enabling the faster and more efficient development of next-generation cancer therapies.
Product Highlights
- Faster Design: The Universal Assembly Platform™ enables rapid and iterative building of libraries of drug candidates from existing components, such as antibody fragments and small molecules.
- Powerful Candidates: Valink’s platform allows us to bring together multiple pieces at once to generate more powerful drug candidates across multiple fields of next-generation antibody engineering, creating unique synergies.
- Better Cures: Valink focuses on treating solid tumors with bispecific antibody-drug conjugates, aiming at two cellular markers at once to differentiate malignant from healthy tissue – this enables us to deliver drugs more specifically and more effectively.
Use Cases
- Cancer Treatment: Valink focuses on developing next-generation cancer therapies, with a focus on solid tumors.
- Antibody Engineering: Valink’s technologies enable next-generation antibody engineering, generating new drug candidates.
- Drug Discovery: Valink’s LiliumX™ platform offers an advanced approach to drug discovery, focusing on the “building block” technology.
Target Audience
Valink provides solutions for pharmaceutical companies, research centers, and healthcare institutions.
